公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2000 | Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives | MING-WHEI YU ; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; CHUN-JEN LIU ; PEI-JER CHEN ; Hsiao T.-J.; PO-HUANG LEE ; Chen C.-J. | Journal of the National Cancer Institute | 210 | 183 | |
2019 | Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B | Wei L.; Pavlovic V.; Bansal A.T.; Chen X.; Foster G.R.; He H.; JIA-HORNG KAO ; Lampertico P.; Liaw Y.-F.; Motoc A.; Papatheodoridis G.V.; Piratvisuth T.; Plesniak R.; Wat C. | Journal of Viral Hepatitis | 2 | 2 | |
2002 | Hepatitis B e antigen and the risk of hepatocellular carcinoma | Yang H.-I.; Lu S.-N.; Liaw Y.-F.; You S.-L.; Sun C.-A.; Wang L.-Y.; CHUHSING KATE HSIAO ; PEI-JER CHEN ; Chen D.-S.; Chen C.-J. | New England Journal of Medicine | 1090 | 938 | |
2010 | Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus Infection | Liaw Y.-F.; Lau G.K.K.; JIA-HORNG KAO ; Gane E. | Digestive Diseases and Sciences | 85 | 74 | |
2011 | Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway | Huang H.-H.; WEI-LIANG SHIH ; Li Y.-H.; Wu C.-F.; PEI-JER CHEN ; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; MING-WHEI YU | Gut | 23 | 23 | |
2005 | Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men | MING-WHEI YU ; Shiou-Hwei Yeh ; PEI-JER CHEN ; Liaw Y.-F.; Lin C.-L.; CHUN-JEN LIU ; WEI-LIANG SHIH ; JIA-HORNG KAO ; DING-SHINN CHEN ; Chen C.-J. | Journal of the National Cancer Institute | 496 | 426 | |
2004 | Hepatitis B virus transmission and hepatocarcinogenesis: A 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma | CHIEN-HUNG CHEN ; Chen Y.Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Lin K.-C.; Tai D.-I.; Changchien C.-S.; Chang W.-Y.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Liaw Y.-F.; Sung J.-L. | Journal of Hepatology | 44 | 32 | |
2016 | The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network | Chang I.-C.; Huang S.-F.; PEI-JER CHEN ; CHI-LING CHEN ; Chen C.-L.; Wu C.-C.; Tsai C.-C.; PO-HUANG LEE ; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F. | Medicine (United States) | 36 | 33 | |
2001 | Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: A nested case-control study among men | MING-WHEI YU ; Yang Y.-C.; Yang S.-Y.; Cheng S.-W.; Liaw Y.-F.; Lin S.-M.; Chen C.-J. | Journal of the National Cancer Institute | 153 | 131 | |
2002 | Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan | MING-WHEI YU ; Chang H.-C.; PEI-JER CHEN ; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. | International Journal of Epidemiology | 27 | 27 | |
2012 | Influences of tobacco and alcohol use on hepatocellular carcinoma survival | WEI-LIANG SHIH ; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; CHUN-JEN LIU ; Lin C.-L.; MING-WHEI YU | International Journal of Cancer | 49 | 44 | |
1996 | L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers | Hsieh L.-L.; Huang R.-C.; MING-WHEI YU ; Chen C.-J.; Liaw Y.-F. | Cancer Letters | 27 | 24 | |
2004 | Lamivudine for patients with chronic hepatitis B and advanced liver disease | Liaw Y.-F.; Sung J.J.Y.; Chow W.C.; Farrell G.; Lee, Cha-Ze ; Yuen H.; Tanwandee T.; Tao Q.-M.; Shue K.; Keene O.N.; Dixon J.S.; Gray D.F.; Sabbat J. | New England Journal of Medicine | 2063 | 1800 | |
2006 | Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area | WEI-LIANG SHIH ; MING-WHEI YU ; PEI-JER CHEN ; Shiou-Hwei Yeh ; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; CHUHSING KATE HSIAO ; Yang S.-Y.; Chen C.-J. | Oncogene | 17 | 14 | |
2010 | Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection | Yang H.-I.; Sherman M.; Su J.; PEI-JER CHEN ; Liaw Y.-F.; Iloeje U.H.; Chen C.-J. | Journal of Clinical Oncology | 219 | 203 | |
1999 | A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers | MING-WHEI YU ; Yang S.-Y.; Chiu Y.-H.; Chiang Y.-C.; Liaw Y.-F.; Chen C.-J. | Hepatology | 136 | 120 | |
2018 | Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B | Hsu C.-W.; Su W.-W.; Lee C.-M.; Peng C.-Y.; Chuang W.-L.; JIA-HORNG KAO ; Chu H.-C.; Huang Y.-H.; Chien R.-N.; Liaw Y.-F. | Journal of the Formosan Medical Association | 20 | 17 | |
1999 | Plasma Carotenoids, Glutathione S-Transferase M1 andT1 Genetic Polymorphisms, and Risk of Hepatocellular Carcinoma: Independent and Interactive Effects | MING-WHEI YU ; Chiu Y.-H.; Chiang Y.-C.; CHIEN-HUNG CHEN ; Lee T.-H.; Santella R.M.; Chern H.-D.; Liaw Y.-F.; Chen C.-J. | American Journal of Epidemiology | 69 | 0 | |
1999 | Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection | MING-WHEI YU ; Horng I.-S.; Hsu K.-H.; Chiang Y.-C.; Liaw Y.-F.; Chen C.-J. | American Journal of Epidemiology | 155 | 124 | |
2003 | Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma | MING-WHEI YU ; Yang S.-Y.; Pan I.-J.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; Chen C.-J. | Journal of the National Cancer Institute | 107 | 95 |